ACHIEVE LIFE SCIENCES, INC. - 10-Q Filing
Achieve Life Sciences filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes details about its June 2025 public offering and subsequent equity financings, including pre-funded warrants issued in private placements. It also outlines financial instruments such as convertible term loans with Silicon Valley Bank and fair value measurements of securities.
Tickers: $ACHV